Log in to save to my catalogue

UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8727673

UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

About this item

Full title

UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2022-01, Vol.126 (1), p.24-33

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Breast cancer has the highest incidence and death rate among cancers in women worldwide. In particular, metastatic estrogen receptor negative (ER–) breast cancer and triple-negative breast cancer (TNBC) subtypes have very limited treatment options, with low survival rates. Ubiquitin carboxyl terminal hydrolase L1 (UCHL1), a ubiquitin C-terminal hyd...

Alternative Titles

Full title

UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8727673

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8727673

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/s41416-021-01516-5

How to access this item